Systematic Review of Combination of Orthokeratology with Atropine in the Treatment of Pediatric Myopia

Authors

  • Melni Armadani Universitas Lampung
  • Diva Shaffa Aisyah
  • Syahrani Alya Murfi
  • Rani Himayani
  • Putu Ristyaning Ayu Sangging

DOI:

https://doi.org/10.53089/medula.v13i4.1.735

Keywords:

Atropin, Myopia, Orthokeratology

Abstract

Myopia is a refractive disorder in which the light rays that enter the eye are focused in front of the retina, not directly above it, so that distant objects appear blurred. Based on several studies, it was found that myopia progresses most rapidly during childhood, and the age of stabilization has been reported to be in the 15-16 year age range. One of the therapies that can be used to slow the progression of myopia is atropine in combination with orthokeratology lenses. The research method was carried out by searching articles on PUBMED with the formula, namely 'Combination Orthokeratology with Atropine' AND 'Myopia' AND Children with a range of 2017 to 2023. Orthokeratology is a method that uses rigid contact lenses designed with a highly oxygen permeable return geometry that helps reshape the central cornea to correct low to moderate refractive errors. The efficiency of orthokeratology in reducing axial elongation in young children has been demonstrated worldwide. Atropine can block muscarinic receptors in the sclera and retina, resulting in thickening of the scleral fibrous layer and thinning of the scleral cartilage layer. This change retards axial elongation and results in recovery of the refractive error. From several existing literature studies, the combination of atropine therapy with orthokeratology lenses has proven effective in slowing the progression or development of myopia in children by suppressing axial elongation.

Author Biographies

Diva Shaffa Aisyah

 

 

Syahrani Alya Murfi

 

 

Rani Himayani

 

 

Putu Ristyaning Ayu Sangging

 

 

References

Baird PN. Myopia. Nat Rev Dis Primer. 2020;6(1):99.

Hao Q, Zhao Q. Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination. Int Ophthalmol.2021;41(9): 2963-2970.

Jonas JB, et.al. IMI Prevention of Myopia and Its Progression. Investigate ophtalmology & visual science. 2021;62(5).

Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kaburaki T, & Kakehashi A. (2020). Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Scientific reports, 10(1): 12750.

Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kakehashi A. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Jpn J Ophthalmol. 2018;62(5): 544-553.

Lee SS & Mackey DA. Prevalence and Risk Factors of Myopia in Young Adults: Review of Findings From the Raine Study. Front Public Health. 2022;27(10): 861044.

Mahayana IT, Indrawati SG & Pawiroranu S. The prevalence of uncorrected refractive error in urban, suburban, exurban and rural primary school children in Indonesian population. Int J Ophthalmol. 2017;10(11): 1771-1776.

Saw SM, Matsumura S, & Hoang QV. Prevention and Management of Myopia and Myopic Pathology. Invest Ophthalmol Vis Sci. 2022;60(2): 488-499.

Saw S, et.al. Prevalence Rates of Refractive Errors in Sumatra, Indonesia. IOVS. 2022;23(10).

Subudhi P & Agarwal P. Myopia. Treasure Islam (FL): Statpearls Publishing. 2022.

Tan Q, Ng AL, Cheng GP, Woo VC, Cho P. Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results. Curr Eye Res. 2019;44(6):671-678.

Ueta T, Makino S, Yamamoto Y, Fukushima H, Yashiro S, & Nagahara, M. Pathologic myopia: an overview of the current understanding and interventions. Global health & medicine. 2020;2(3), 151–155.

Yu S, et.al. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial, BMJ Ophtalmology. 2022;22(438).

Yuan Y, Zhu C, Liu M, Zhou Y, Yang X, Zheng B, Li Z, Mao X, & Ke B. Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial. Trials. 2021;22(1), 863.

Zhao Q & Hao Q. Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children. Int Ophtalmol. 2021;41, 1011-1017.

Zhou H, Zhao G, & Li Y. Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia. Clinical and Experimental Optometry. 2021.

Published

2023-05-31

How to Cite

Armadani, M., Aisyah, D. S., Syahrani Alya Murfi, Himayani, R., & Ayu Sangging, P. R. (2023). Systematic Review of Combination of Orthokeratology with Atropine in the Treatment of Pediatric Myopia. Medical Profession Journal of Lampung, 13(4.1), 134-143. https://doi.org/10.53089/medula.v13i4.1.735

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 > >>